Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple mutations and cancer.

Lawrence A Loeb1, Keith R Loeb, Jon P Anderson

  • 1Joseph Gottstein Memorial Cancer Research Laboratory, Department of Pathology, University of Washington School of Medicine, Seattle, WA 98195-7705, USA. laloeb@u.washington.edu

Proceedings of the National Academy of Sciences of the United States of America
|January 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of hematopoietic stem cell-derived microglia-like cells in nonhuman primates.

Blood advances·2026
Same author

[211At]Astatine-Based Conditioning with a Humanized CD45 Antibody for Autologous Hematopoietic Stem Cell Gene Therapy.

Blood·2026
Same author

CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target.

The Journal of clinical investigation·2024
Same author

CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology Group.

Haematologica·2024
Same author

Cytokine release syndrome after bronchoalveolar lavage.

BMC pulmonary medicine·2023
Same author

Donor bone marrow-derived macrophage engraftment into the central nervous system of patients following allogeneic transplantation.

Blood advances·2023
Same journal

Chemotactic self-organization captures the dynamics of mammalian hair follicle patterning.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Tomographic imaging of superconducting order using particle-hole interference.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inferring epidemiological parameters under an infectious phylogeography model with visitor dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Analytical modeling for suction cup designs for skin-interfaced wearable devices.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Improving cell-free metabolism through direct integration of artificial respiratory chains.

Proceedings of the National Academy of Sciences of the United States of America·2026
See all related articles

Human tumors exhibit significant heterogeneity, likely driven by a mutator phenotype. This suggests cancers develop an accelerated mutation rate early in their evolution, impacting prognosis and treatment.

Area of Science:

  • Oncology
  • Cancer Biology
  • Genetics

Background:

  • Human tumors display substantial heterogeneity.
  • This heterogeneity is hypothesized to arise from a mutator phenotype.
  • Normal mutation rates may not explain the extensive genetic alterations in cancer.

Purpose of the Study:

  • To review the current understanding of the mutator phenotype hypothesis in human cancers.
  • To explore the implications of this hypothesis for cancer prognosis.
  • To examine the impact on cancer treatment and prevention strategies.

Main Methods:

  • Review of existing scientific literature on cancer heterogeneity and mutator phenotypes.
  • Analysis of the theoretical underpinnings of the mutator phenotype hypothesis.

Related Experiment Videos

  • Discussion of clinical and translational implications.

    • Main Results:

    • The mutator phenotype provides a plausible explanation for the rapid accumulation of mutations in cancer.
    • Evidence suggests that a mutator phenotype can arise early in tumor development.
    • This phenotype has significant implications for understanding tumor evolution.

    Conclusions:

    • The mutator phenotype hypothesis offers a framework for understanding cancer heterogeneity.
    • Addressing the mutator phenotype may be crucial for improving cancer prognosis and treatment outcomes.
    • Further research into the mutator phenotype could lead to novel prevention strategies.